CRF : eDiary - Electronic Patient Diaries - Clinical Trials

Our Experience

CRF Inc. is recognized as the industry leader for Electronic Patient Diary solutions. Our experience with multinational clinical programs is unsurpassed.

The TrialMax® eDiary solution from CRF Inc. can deliver:

Studies from 50 to 15,000+ patients
Across 2 to 200+ sites
Experience in 45 indications
Deployment in 55 countries
User acceptance from children to the elderly and terminally ill
Typical compliance rates of 95%

Our experience includes some of the industry’s most challenging studies, for example:

Our largest study included 15,000 patients.
Novartis Zelmac® phase III study with 5,000 gastrointestinal patients in 23 countries reporting primary efficacy data with 96% compliance rate and database closed 5 days after Last Patient Last Visit (LPLV).

To date 36 of our deliveries will be forming part of the client’s FDA and EMEA submission activities. 6 have been submitted successfully.

Over 105,000 patients, from children to the elderly, have successfully used our solution, completing 58 million eDiary pages at more than 5,000 sites through 55 countries in 52 languages and across 45 indications, yielding an average compliance rate of 95%.

50% of the studies larger than 500 patients

Strong experience across therapeutic areas